A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma

NCT01377025 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: Placebo
DRUG: Sorafenib
DRUG: Sorafenib

Sponsor

Prof. Dr. med. Max. E. Scheulen

Collaborators

[object Object]